ABVC Biopharma: Below And (ii) The Unaudited Pro Forma Condensed Combined Financial Statements As Of And For The Ninemonth Period Ended September 30, 2023, Referred To In Item 9.01(b) Below
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameABVC Biopharma Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









